Breast Implants Market Size, Share, and Trends 2024 to 2033

The global breast implants market size surpassed USD 2.6 billion in 2023 and is projected to hit around USD 5.38 billion by 2033, growing at a CAGR of 7.60% from 2024 to 2033.

Key Takeaways

• North America dominated the market with 32% of market share in 2023.
• while Asia Pacific is expected to witness the fastest rate of growth during the forecast period.
• By product, silicone breast implants accounted for the dominating share of 83% in the year 2023.
• By product, the saline breast implants segment accounted for the considerable growth in the global breast implants market over the forecast period.
• By application, the reconstructive surgery segment held the largest share of the breast implants market in 2023.
• by application, the cosmetic surgery segment is expected to grow significantly during the forecast period.
• By end-user, the hospitals segment held the largest share of the market in 2023.

Breast Implants Market in the U.S. 2024 to 2033

The U.S. breast implants market size was estimated at USD 580 million in 2023 and is anticipated to reach around USD 1,220 million by 2033, growing at a CAGR of 7.70% from 2024 to 2033.

North America held the largest share of 32% in the breast implants market in 2023. The growth of the region is attributed to the presence of the sophisticated healthcare infrastructure, increasing use of medical devices, increasing investment in the healthcare sector, rising research and development activities, technological advancement in medical devices, rising awareness campaigns regarding breast implants, and rising burden of breast cancer which results in increasing demand for breast implants surgeries in the region.

• In July 2023, Canadian plastic surgeons can now offer women the latest generation of breast implants with clinically proven low complication rates. Sientra, distributed by Clarion Medical Technologies, is the first new silicone gel breast implant manufacturer to be approved by Health Canada in nearly 20 years. Their high-strength cohesive silicone gel breast implants feature the latest generational gel technology and are backed by clinically proven data.

The United States is one of the major contributors to the breast implants market. The growth of the market is driven by several factors, such as the increasing number of cosmetic surgeries, increasing product approvals by various regulatory organizations, rising disposable income, rising medical tourism, rising women's inclination toward breast augmentation and reconstruction procedures for beauty enhancement, and increasing prevalence of breast cancer.

• In November 2023, RTI Surgical, a leading global medical device organization, announced that the U.S. Food and Drug Administration (FDA) granted Investigational Device Exemption (IDE) approval for a clinical study designed to confirm the safety and effectiveness of Cortiva Allograft Dermis in implant-based breast reconstruction.

Asia-Pacific breast implants market is expected to grow at a significant CAGR in the coming years. The growth of the market is due to several factors, such as rising demand for cosmetic procedures, increasing prevalence of breast cancer, rising awareness campaigns, the rising potential of the healthcare sector in developing markets, and rising strategic initiatives and product innovations. The wide use of artificial devices (prostheses) coupled with rising investment in advanced technologies in the healthcare sector is increasing the demand for breast implants.

Breast Implants Market Overview

People who get breast implants want to enhance the size and shape of their natural breasts. Breast implants are medical devices that are surgically inserted into the breasts. In recent years, breast implants have gained attention rapidly and have made incredible progress in yielding natural-feeling results. Breast implants are the most popular type of plastic surgery prostheses. Generally, there are two types of breast implants: saline and silicone gel. Breast implants come in different shapes and sizes according to the individual's needs. The breast implants market encompasses the activities of manufacturing, selling, and distributing breast implants.

Breast Implants Market Data and Statistics

• As of June 30, 2023, the U.S. FDA has received a total of 1264 U.S. and global medical device reports (MDRs) of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL).
• In June 2023, VSS Capital Partners, an investment firm investing in the healthcare, education, and business services industries, announced an investment in Olympus Cosmetic Group, a newly formed platform providing comprehensive cosmetic surgery, dermatological treatments, and non-surgical cosmetic procedures.
• In November 2023, Allergan Aesthetics embraces the immensely personal choice that patients experience when choosing breast surgery. The new Natrelle campaign, 'For Every Body,' highlights patients and their diverse stories, leveraging new imagery and visual assets. The campaign showcases how the Natrelle breast implant portfolio can offer a customized look.

Breast Implants Market Scope

Breast Implants Market Dynamics

Driver: Increasing prevalence of breast cancer

Breast cancer is the most common disorder. This increasing prevalence of breast cancer across the globe has increased the need for breast reconstruction procedures, which can involve the use of breast implant surgeries. Therefore, with increasing cases of breast cancer, the demand for breast implants as a treatment option is anticipated to fuel the growth of the global breast implants market in the coming years.

• According to the American Cancer Society report published in 2023, Nearly 30% of all newly diagnosed cancers in women are breast cancer in the United States. Currently, there are more than 4 million women with a history of breast cancer in the U.S., which includes women currently being treated and women who have finished treatment.

Restraint: High cost

The high cost associated with breast implant surgeries is observed to hamper the market's growth. An individual needs to invest high capital to undergo breast implant surgeries. In addition, risks associated with breast implants and post-surgery complications may restrain the market's growth during the forecast period. The side effects of breast implants include infection in the nipples, breast pain, and breast sensation, which may limit the adoption and restrict the expansion of the global breast implants market.

Opportunity: Rising demand for cosmetic procedures

The rising demand for cosmetic procedures for aesthetic appeal is projected to offer lucrative opportunities to the market during the forecast period. An individual undergoes breast implant surgeries to achieve an aesthetic appearance, which is mostly influenced by the growing hype of aesthetic appearance standards in society and social media.

Breast implants are one of the most popular cosmetic procedures for individuals seeking body transformation to be attractive. Breast implants assist in enhancing the breasts' shape, size, and symmetry according to the individual's desired aesthetic appearance, which also results in boosting their self-confidence. Therefore, increasing demand for cosmetic procedures globally is expected to spur the demand for breast implants in the coming years.

According to the report published by the International Society of Aesthetic Plastic Surgery in 2022, breast augmentation remains the most common surgical procedure for women, with 2.2 million procedures and a significant increase of 29 percent compared to 2021. All breast procedures witnessed significant growth from the previous year, with more than 4.4 million procedures on breasts and a 25 percent increase.

Product Insights

The silicone breast implants segment dominated the market with 83% market share in 2023; the segment is observed to grow in the coming years. Silicone breast implants offer a more natural feel than saline breast implants. Soft textured breast implants from silicone are filled with a silicone gel, and this gel is similar to natural breast tissue, which also has less risk of forming hard scar tissue around the implantation. In case of leakage, the gel may remain within the implant shell. Silicone breast implants are FDA-approved for augmentation in women aged 22 or above.

• According to the report published by the International Society of Aesthetic Plastic Surgery in 2022, breast augmentation remains the most common surgical procedure for women, with 2.2 million procedures and a significant increase of 29 percent compared to 2021. All breast procedures witnessed significant growth from the previous year, with more than 4.4 million procedures on breasts and a 25 percent increase.

The saline breast implants segment is expected to grow at a rapid CAGR rate during the forecast period. Saline breast implants are filled with sterile salt water. These implants offer a consistent shape and firmness. Saline breast implants are FDA-approved for augmentation in women aged 18 or above. In case of leakage, saline implants get absorbed naturally into the body without causing any harm.

Application Insights

The reconstructive surgery segment dominated the breast implant market in 2023. The segment is observed to sustain the position throughout the forecast period. Reconstructive surgery deals with the defects and deformities of the chest wall and post-mastectomy procedure. Reconstruction surgery is conducted to restore the natural look and improve physical appearance to become more esthetic.

Advances in surgical techniques, implant designs, and materials have improved the safety, durability, and aesthetic outcomes of breast reconstruction with implants. Surgeons have access to a variety of implant options, including saline, silicone gel, and structured implants, to meet the diverse needs of patients. Overall, reconstructive surgeries with breast implants offer a viable and effective option for individuals seeking to restore breast appearance, symmetry, and confidence following mastectomy, breast deformities, or other related conditions. The popularity of these procedures underscores their significant impact on physical and emotional well-being, empowering patients to reclaim their bodies and lives.

End-User Insights

The hospitals segment dominated the breast implants market in 2023. Hospitals provide access to advanced machines for patients. Individuals seeking body transformation mostly choose hospitals to undergo breast augmentation procedures as they offer more efficient solutions. Such supportive factors are fueling the segment’s dominance in the market.

Recent Developments

• In January 2023, Establishment Labs Holdings Inc., a leading medical technology company, announced Seishin Plastic and Aesthetic Surgery Clinic in Japan as the First Clinic Partner in the Global Launch of Mia Femtech. Establishment Labs Holdings Inc. is dedicated to improving women's health and wellness, particularly in breast aesthetics and reconstruction.
• In January 2022, Mentor Worldwide LLC received the U.S. FDA for the MENTOR Memory Gel BOOST, a breast implant for breast augmentation in women of women aged 22 years and above.

Breast Implants Market Companies

• Sientra, Inc.
• Shanghai Kangning Medical Supplies Ltd.
• Sebbin
• Polytech Health and Aesthetics GmBH
• Mentor Worldwide LLC
• Laboratoires Arion
• HansBioMed
• Guangzhou Wanhe Plastic Materials Co., Ltd.
• GC Aesthetics
• Establishment Labs S.A.
• CEREPLAS
• Allergan plc
• AbbVie Inc.

Segments Covered in the Report

By Product

• Silicone Breast Implants
• Saline Breast Implants

By Application

• Reconstructive Surgery
• Cosmetic Surgery

By End-User

• Hospitals
• Cosmetology Clinics
• Others

By Geography

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa